Status:
WITHDRAWN
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Conditions:
Obesity
Inflammation
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
The main objective is to determine the effect that supplementation with 4.8 g/day of w-3 FA \[3.2g eicosapentaenoic acid (EPA) and 1.6 g docosahexaenoic acid (DHA)\] have on the inflammatory state of ...
Detailed Description
Methodology Study design. This is a prospective, experimental, comparative, non-blinded (open) study. Adult obese (BMI ≥ 35.0 kg/m2) patients, age 25 to 45 y, of any gender will be recruited from the...
Eligibility Criteria
Inclusion
- Control group:
- healthy adult non-obese volunteers (BMI 18.5 to 23.0 kg/m2)
- Obese group:
- metabolically healthy adult obese (BMI ≥ 35.0 kg/m2) patients,
Exclusion
- type 2 diabetes
- hypertension
- liver or kidney failure
- metabolic syndrome
- taking antinflammatory drugs or dietary supplements
- in the case of women, pregnant or lactating
Key Trial Info
Start Date :
January 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05219890
Start Date
January 16 2017
End Date
January 1 2024
Last Update
March 15 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.